94 related articles for article (PubMed ID: 31401124)
1. Characterization of Reference Materials for Genetic Testing of CYP2D6 Alleles: A GeT-RM Collaborative Project.
Gaedigk A; Turner A; Everts RE; Scott SA; Aggarwal P; Broeckel U; McMillin GA; Melis R; Boone EC; Pratt VM; Kalman LV
J Mol Diagn; 2019 Nov; 21(6):1034-1052. PubMed ID: 31401124
[TBL] [Abstract][Full Text] [Related]
2. Establishment of CYP2D6 reference samples by multiple validated genotyping platforms.
Fang H; Liu X; Ramírez J; Choudhury N; Kubo M; Im HK; Konkashbaev A; Cox NJ; Ratain MJ; Nakamura Y; O'Donnell PH
Pharmacogenomics J; 2014 Dec; 14(6):564-72. PubMed ID: 24980783
[TBL] [Abstract][Full Text] [Related]
3. Development of genomic reference materials for cystic fibrosis genetic testing.
Pratt VM; Caggana M; Bridges C; Buller AM; DiAntonio L; Highsmith WE; Holtegaard LM; Muralidharan K; Rohlfs EM; Tarleton J; Toji L; Barker SD; Kalman LV
J Mol Diagn; 2009 May; 11(3):186-93. PubMed ID: 19359498
[TBL] [Abstract][Full Text] [Related]
4. Quality score compression improves genotyping accuracy.
Yu YW; Yorukoglu D; Peng J; Berger B
Nat Biotechnol; 2015 Mar; 33(3):240-3. PubMed ID: 25748910
[No Abstract] [Full Text] [Related]
5. PharmVar GeneFocus: CYP2D6.
Nofziger C; Turner AJ; Sangkuhl K; Whirl-Carrillo M; Agúndez JAG; Black JL; Dunnenberger HM; Ruano G; Kennedy MA; Phillips MS; Hachad H; Klein TE; Gaedigk A
Clin Pharmacol Ther; 2020 Jan; 107(1):154-170. PubMed ID: 31544239
[TBL] [Abstract][Full Text] [Related]
6. Characterization of Reference Materials with an Association for Molecular Pathology Pharmacogenetics Working Group Tier 2 Status: CYP2C9, CYP2C19, VKORC1, CYP2C Cluster Variant, and GGCX: A GeT-RM Collaborative Project.
Pratt VM; Turner A; Broeckel U; Dawson DB; Gaedigk A; Lynnes TC; Medeiros EB; Moyer AM; Requesens D; Vetrini F; Kalman LV
J Mol Diagn; 2021 Aug; 23(8):952-958. PubMed ID: 34020041
[TBL] [Abstract][Full Text] [Related]
7. Resolving discordant
Hongkaew Y; Wang WY; Gaedigk R; Sukasem C; Gaedigk A
Pharmacogenomics; 2021 Jun; 22(9):529-541. PubMed ID: 33998274
[No Abstract] [Full Text] [Related]
8. Star allele search: a pharmacogenetic annotation database and user-friendly search tool of publicly available 1000 Genomes Project biospecimens.
Gharani N; Calendo G; Kusic D; Madzo J; Scheinfeldt L
BMC Genomics; 2024 Jan; 25(1):116. PubMed ID: 38279110
[TBL] [Abstract][Full Text] [Related]
9. Targeted haplotyping in pharmacogenomics using Oxford Nanopore Technologies' adaptive sampling.
Deserranno K; Tilleman L; Rubben K; Deforce D; Van Nieuwerburgh F
Front Pharmacol; 2023; 14():1286764. PubMed ID: 38026945
[TBL] [Abstract][Full Text] [Related]
10. Frequencies of pharmacogenomic alleles across biogeographic groups in a large-scale biobank.
Li B; Sangkuhl K; Whaley R; Woon M; Keat K; Whirl-Carrillo M; Ritchie MD; Klein TE
Am J Hum Genet; 2023 Oct; 110(10):1628-1647. PubMed ID: 37757824
[TBL] [Abstract][Full Text] [Related]
11. PharmVar Tutorial on CYP2D6 Structural Variation Testing and Recommendations on Reporting.
Turner AJ; Nofziger C; Ramey BE; Ly RC; Bousman CA; Agúndez JAG; Sangkuhl K; Whirl-Carrillo M; Vanoni S; Dunnenberger HM; Ruaño G; Kennedy MA; Phillips MS; Hachad H; Klein TE; Moyer AM; Gaedigk A
Clin Pharmacol Ther; 2023 Dec; 114(6):1220-1237. PubMed ID: 37669183
[TBL] [Abstract][Full Text] [Related]
12. The Genetic Testing Reference Materials Coordination Program: Over 10 Years of Support for Pharmacogenomic Testing.
Scott SA
J Mol Diagn; 2023 Sep; 25(9):630-633. PubMed ID: 37481236
[No Abstract] [Full Text] [Related]
13. Computational pharmacogenotype extraction from clinical next-generation sequencing.
Shugg T; Ly RC; Osei W; Rowe EJ; Granfield CA; Lynnes TC; Medeiros EB; Hodge JC; Breman AM; Schneider BP; Sahinalp SC; Numanagić I; Salisbury BA; Bray SM; Ratcliff R; Skaar TC
Front Oncol; 2023; 13():1199741. PubMed ID: 37469403
[TBL] [Abstract][Full Text] [Related]
14. Characterization of complex structural variation in the
Turner AJ; Derezinski AD; Gaedigk A; Berres ME; Gregornik DB; Brown K; Broeckel U; Scharer G
Front Pharmacol; 2023; 14():1195778. PubMed ID: 37426826
[TBL] [Abstract][Full Text] [Related]
15. PAnno: A pharmacogenomics annotation tool for clinical genomic testing.
Liu Y; Lin Z; Chen Q; Chen Q; Sang L; Wang Y; Shi L; Guo L; Yu Y
Front Pharmacol; 2023; 14():1008330. PubMed ID: 36778023
[No Abstract] [Full Text] [Related]
16. An efficient genotyper and star-allele caller for pharmacogenomics.
Hari A; Zhou Q; Gonzaludo N; Harting J; Scott SA; Qin X; Scherer S; Sahinalp SC; Numanagić I
Genome Res; 2023 Jan; 33(1):61-70. PubMed ID: 36657977
[TBL] [Abstract][Full Text] [Related]
17. Physiologically based pharmacokinetic (PBPK) modeling of the role of CYP2D6 polymorphism for metabolic phenotyping with dextromethorphan.
Grzegorzewski J; Brandhorst J; König M
Front Pharmacol; 2022; 13():1029073. PubMed ID: 36353484
[TBL] [Abstract][Full Text] [Related]
18. How to Run the Pharmacogenomics Clinical Annotation Tool (PharmCAT).
Li B; Sangkuhl K; Keat K; Whaley RM; Woon M; Verma S; Dudek S; Tuteja S; Verma A; Whirl-Carrillo M; Ritchie MD; Klein TE
Clin Pharmacol Ther; 2023 May; 113(5):1036-1047. PubMed ID: 36350094
[TBL] [Abstract][Full Text] [Related]
19. Characterization of Novel
Wang WY; Twesigomwe D; Nofziger C; Turner AJ; Helmecke LS; Broeckel U; Derezinski AD; Hazelhurst S; Gaedigk A
J Pers Med; 2022 Sep; 12(10):. PubMed ID: 36294714
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
